White Square Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

White Square Capital’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-112,500	Closed	-$6.73M	–	22
2019 Q4	$6.73M	Buy	+112,500	New	+$4.22M	4.87%	6

White Square Capital's BOLD Position: Q1 2020 in Review

White Square Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 112,500 shares — an estimated $6.73M sold.

White Square Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $6.73M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

White Square Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
White Square Capital sold 112,500 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $6.73M.
White Square Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
White Square Capital's Audentes Therapeutics, Inc position peaked at $6.73M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on White Square Capital's 13F filing for Q1 2020, filed 14 May 2020.